Sumatriptan
Manus Aktteva Biopharma LLP, a global supplier of Sumatriptan, 103628-46-2 offers for your requirements of RND / Development quantities or commercials, based on status of the product. We can also offer its intermediates with supportive technical package required for evaluation.
Chemical Name:
1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide, Sumatriptan
Pharmacopeia:
USP, EP, BP
Certificate:
GMP, cGMP, EUGMP, WHO GMP, ISO Certified, USFDA, Cofepris Mexico, Korea FDA
Application:
For R&D Purpose
Email To:
Your Email:
Your Name:
Note:
Processing....
Synonym
1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide, Sumatriptan
Specifications
Available on request
Packing
Export worthy packing
Material Safety Data Sheet
Available on request
| Product Name |
CAS No. |
|
| Sodium cyanoborohydride |
25895-60-7 |
View | Inquire |
| 4,4-Diethoxy-N,N-dimethyl-1-butanamine |
1116-77-4 |
View | Inquire |
| 4-Chlorobutanal diethyl acetal |
6139-83-9 |
View | Inquire |
| N-Methyl-4-diazanylsulfabenzamide |
88933-16-8 |
View | Inquire |
| Sodium 4-chloro-1-hydroxybutanesulfonate |
54322-20-2 |
View | Inquire |
| 3-(2-Aminoethyl)-N-methyl-1H-indole-5-methanesulfonamide |
88919-22-6 |
View | Inquire |
| 4-Hydrazino-N-methylbenzenemethanesulfonamide |
139272-29-0 |
View | Inquire |
Description:
Sumatriptan, CAS NO 103628-46-2, is a synthetic drug belonging to the triptan class, used for the treatment of migraine headaches. Sumatriptan is used to treat migraines. It helps to relieve headaches, pain and other symptoms of migraines, including sensitivity to light/sound, nausea, and vomiting. Sumatriptan succinate constricts bloodvessels and is used to treat migraine attacks. During migraine attacks certain bloodvessels in the brain become enlarged and this causes pain. Manus Aktteva Biopharma LLP, a global supplier of Oxyclozanide offers for your requirements with supportive technical package equired for evaluation.
- Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
- Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
- Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
- Manus Aktteva Biopharma LLP assumes no responsibility/liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual. Manus Aktteva makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents in its products or services for any purpose.
- Manus Aktteva Biopharma LLP warns the sellers not to sell any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual.
- Manus Aktteva Biopharma LLP warns the buyers not to use/procure any goods to achieve a product which might be knowingly causing an infringement of intellectual property in any manner whatsoever which includes patent rights of any individual.
Are you looking for Sumatriptan with documentation like PMDA - JAPAN, DMF - CANADA, TGA - AUSTRALIA, DMF (OPEN PART), DMF (CLOSED PART), MHRA - UK, DMF - KOREA, AIFA - ITALY, MEDSAFE - NEW ZEALAND, HEALTH CANADA, JDMF, JAPAN - AFM, DCGI, COPP, TDMF, Written Confirmation? Please
click here to send us sourcing request.
Sumatriptan, 103628-46-2, USDMF, EDMF, CEP / COS, TDP, DMF - CTD, ICH, GMP, cGMP, EUGMP, WHO GMP, ISO Certified, USFDA, Cofepris Mexico, Korea FDA, Price, Cost, Manufacturer, Exporter, Supplier, India, China, MSDS
Queries
Easy ways to get the answers you need.
+91 79 26463395
+91 79 26463395
